162 related articles for article (PubMed ID: 28317063)
1. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
[TBL] [Abstract][Full Text] [Related]
2. The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis.
Tam HH; Collins DJ; Brown G; Chau I; Cunningham D; Leach MO; Koh DM
Br J Radiol; 2013 Oct; 86(1030):20130281. PubMed ID: 23995873
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a Simplified Intravoxel Incoherent Motion (IVIM) Analysis of Diffusion-Weighted Imaging for Prediction of Tumor Size Changes and Imaging Response in Breast Cancer Liver Metastases Undergoing Radioembolization: A Retrospective Single Center Analysis.
Pieper CC; Sprinkart AM; Meyer C; König R; Schild HH; Kukuk GM; Mürtz P
Medicine (Baltimore); 2016 Apr; 95(14):e3275. PubMed ID: 27057887
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Survival after Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases.
Weiner AA; Gui B; Newman NB; Nosher JL; Yousseff F; Lu SE; Foltz GM; Carpizo D; Lowenthal J; Zuckerman DA; Benson B; Olsen JR; Jabbour SK; Parikh PJ
J Vasc Interv Radiol; 2018 Aug; 29(8):1094-1100. PubMed ID: 29754852
[TBL] [Abstract][Full Text] [Related]
5. Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system.
Damm R; Seidensticker R; Ulrich G; Breier L; Steffen IG; Seidensticker M; Garlipp B; Mohnike K; Pech M; Amthauer H; Ricke J
BMC Cancer; 2016 Jul; 16():509. PubMed ID: 27439702
[TBL] [Abstract][Full Text] [Related]
6. Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and
Uutela A; Ovissi A; Hakkarainen A; Ristimäki A; Lundbom N; Kallio R; Soveri LM; Salminen T; Ålgars A; Halonen P; Ristamäki R; Nordin A; Blanco Sequeiros R; Rinta-Kiikka I; Lantto E; Virtanen J; Pääkkö E; Liukkonen E; Saunavaara J; Ryymin P; Lammentausta E; Osterlund P; Isoniemi H;
ESMO Open; 2021 Aug; 6(4):100208. PubMed ID: 34325107
[TBL] [Abstract][Full Text] [Related]
7. Patterns of failure in colorectal patients with liver metastases after yttrium-90 radioembolization.
Schonewolf CA; Patel B; Gensure RH; Narra V; Haffty BG; Nosher JL; Jabbour SK
Am J Clin Oncol; 2014 Jun; 37(3):234-40. PubMed ID: 23275270
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine liver metastases treated using transarterial radioembolization: Identification of prognostic parameters at 68Ga-DOTATATE PET/CT.
Ingenerf M; Grawe F; Winkelmann M; Karim H; Ruebenthaler J; Fabritius MP; Ricke J; Seidensticker R; Auernhammer CJ; Zacherl MJ; Seidensticker M; Schmid-Tannwald C
Diagn Interv Imaging; 2024 Jan; 105(1):15-25. PubMed ID: 37453859
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis.
Gonsalves CF; Eschelman DJ; Adamo RD; Anne PR; Orloff MM; Terai M; Hage AN; Yi M; Chervoneva I; Sato T
Radiology; 2019 Oct; 293(1):223-231. PubMed ID: 31453767
[TBL] [Abstract][Full Text] [Related]
10. Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases.
Karim S; Seidensticker R; Seidensticker M; Ricke J; Schinner R; Treitl K; Rübenthaler J; Ingenerf M; Schmid-Tannwald C
Radiol Oncol; 2024 Mar; 58(1):33-42. PubMed ID: 38378033
[TBL] [Abstract][Full Text] [Related]
11. Value of multiple models of diffusion-weighted imaging to predict hepatic lymph node metastases in colorectal liver metastases patients.
Zhu HB; Zhao B; Li XT; Zhang XY; Yao Q; Sun YS
World J Gastroenterol; 2024 Jan; 30(4):308-317. PubMed ID: 38313236
[TBL] [Abstract][Full Text] [Related]
12. Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases.
Smits ML; van den Hoven AF; Rosenbaum CE; Zonnenberg BA; Lam MG; Nijsen JF; Koopman M; van den Bosch MA
PLoS One; 2013; 8(7):e69448. PubMed ID: 23894481
[TBL] [Abstract][Full Text] [Related]
13. Whole tumor based texture analysis of magnetic resonance diffusion imaging for colorectal liver metastases: A prospective study for diffusion model comparison and early response biomarker.
Li Y; Zhang H; Yue L; Fu C; Grimm R; Li W; Guo W; Tong T
Eur J Radiol; 2024 Jan; 170():111203. PubMed ID: 38007855
[TBL] [Abstract][Full Text] [Related]
14. Predictive Partition Dosimetry and Outcomes after Yttrium-90 Resin Microsphere Radioembolization of Colorectal Cancer Metastatic to the Liver: A Retrospective Analysis.
Doyle PW; Workman CS; Shah N; McGonigle TW; Grice JV; Huang S; Borgmann AJ; Baker JC; Guys NP; Taylor JE; Brown DB
J Vasc Interv Radiol; 2023 Dec; 34(12):2138-2146. PubMed ID: 37640105
[TBL] [Abstract][Full Text] [Related]
15. Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.
Chapiro J; Duran R; Lin M; Schernthaner R; Lesage D; Wang Z; Savic LJ; Geschwind JF
Eur Radiol; 2015 Jul; 25(7):1993-2003. PubMed ID: 25636420
[TBL] [Abstract][Full Text] [Related]
16. Incremental value of volumetric multiparametric MRI over Fudan score for prognosis of unresectable intrahepatic cholangiocarcinoma treated with systemic chemotherapy.
Pandey A; Mohseni A; Shaghaghi M; Pandey P; Rezvani Habibabadi R; Hazhirkarzar B; Ly A; Panid Madani S; Borhani A; Kamel IR
Eur J Radiol; 2024 Jan; 170():111196. PubMed ID: 38029705
[TBL] [Abstract][Full Text] [Related]
17. Prognostic prediction of resectable colorectal liver metastasis using the apparent diffusion coefficient from diffusion-weighted magnetic resonance imaging.
Yoshikawa M; Morine Y; Yamada S; Miyazaki K; Tokuda K; Saito Y; Arakawa Y; Ikemoto T; Imura S; Shimada M
Ann Gastroenterol Surg; 2021 Mar; 5(2):252-258. PubMed ID: 33860146
[TBL] [Abstract][Full Text] [Related]
18. Local Tumor Progression Predictive Model Based on MRI for Colorectal Cancer Liver Metastases after Radiofrequency Ablation.
Zhang G; Liu P; Wang G; He X; Xu L; Wang Y; Li W; Peng W
Discov Med; 2024 Apr; 36(183):765-777. PubMed ID: 38665025
[TBL] [Abstract][Full Text] [Related]
19. Radiomics-Based Prediction Model for Outcome of Radioembolization in Metastatic Colorectal Cancer.
Roll W; Masthoff M; Köhler M; Rahbar K; Stegger L; Ventura D; Morgül H; Trebicka J; Schäfers M; Heindel W; Wildgruber M; Schindler P
Cardiovasc Intervent Radiol; 2024 Apr; 47(4):462-471. PubMed ID: 38416178
[TBL] [Abstract][Full Text] [Related]
20. The Apparent Diffusion Coefficient of the Paraspinal and Psoas Muscles Are of Prognostic Relevance in Patients With Hepatocellular Carcinoma Undergoing Transarterial Radioembolization.
Ehrengut C; Schindler A; Seehofer D; Ebel S; Steinhoff K; Sabri O; Berg T; Denecke T; Bömmel FV; Meyer HJ
Cancer Diagn Progn; 2024; 4(3):281-287. PubMed ID: 38707727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
